Skip to main content
Premium Trial:

Request an Annual Quote

Pyrosequencing Sells High-Throughput Genotyping System to Oxagen

hNEW YORK, Aug 9 – Pyrosequencing of Uppsala, Sweden said Thursday it had sold a high-throughput PTP genotyping system to Oxagen, a British genomics company.

The deal is the second one between the two companies. Several months ago, Oxagen purchased Pyrosequencing’s PSQ 96 System, a moderate-throughput genotyping system. 

The PTP system is an automated system that uses robotics for sample preparation and contains 384-wellplates. The system is able to score up to 100,000 SNPs per day, Pyrosequencing said. 

Oxagen is conducting family studies as a way of gaining insight into genetic variation. 

"PTP should enable us to scale- up our SNP genotyping capacity based on a proven technology and to reach results at greater speed and lower cost without loss of quality,” Trevor Nicholls, CEO of Oxagen, said in a statement. 

Pyrosequencing said it has so far sold more than 100 of systems to customers around the world.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.